JP2009502788A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502788A5 JP2009502788A5 JP2008522861A JP2008522861A JP2009502788A5 JP 2009502788 A5 JP2009502788 A5 JP 2009502788A5 JP 2008522861 A JP2008522861 A JP 2008522861A JP 2008522861 A JP2008522861 A JP 2008522861A JP 2009502788 A5 JP2009502788 A5 JP 2009502788A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- group
- piperazinyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 29
- -1 monosubstituted amino Chemical group 0.000 claims 24
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- 125000004193 piperazinyl group Chemical group 0.000 claims 19
- 125000003107 substituted aryl group Chemical group 0.000 claims 18
- 125000003710 aryl alkyl group Chemical group 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 125000003386 piperidinyl group Chemical group 0.000 claims 17
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 16
- 125000000753 cycloalkyl group Chemical group 0.000 claims 14
- 125000002757 morpholinyl group Chemical group 0.000 claims 13
- 150000002431 hydrogen Chemical class 0.000 claims 12
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000003921 oil Substances 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 208000027030 Premenstrual dysphoric disease Diseases 0.000 claims 2
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims 2
- 102000002852 Vasopressins Human genes 0.000 claims 2
- 108010004977 Vasopressins Proteins 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 230000008485 antagonism Effects 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims 2
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 2
- 125000005127 aryl alkoxy alkyl group Chemical group 0.000 claims 2
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 2
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229960003726 vasopressin Drugs 0.000 claims 2
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 0 *C(C1(*)*)N(C(*)(*)C(*)=O)C1=O Chemical compound *C(C1(*)*)N(C(*)(*)C(*)=O)C1=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70067305P | 2005-07-19 | 2005-07-19 | |
| US60/700,673 | 2005-07-19 | ||
| PCT/US2006/027703 WO2007011878A2 (en) | 2005-07-19 | 2006-07-18 | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013044654A Division JP2013151520A (ja) | 2005-07-19 | 2013-03-06 | ベータ−ラクタミルフェニルアラニン、システイン、およびセリン・バソプレッシン拮抗剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009502788A JP2009502788A (ja) | 2009-01-29 |
| JP2009502788A5 true JP2009502788A5 (enExample) | 2009-10-08 |
| JP5328349B2 JP5328349B2 (ja) | 2013-10-30 |
Family
ID=37529732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008522861A Expired - Fee Related JP5328349B2 (ja) | 2005-07-19 | 2006-07-18 | ベータ−ラクタミルフェニルアラニン、システイン、およびセリン・バソプレッシン拮抗剤 |
| JP2013044654A Pending JP2013151520A (ja) | 2005-07-19 | 2013-03-06 | ベータ−ラクタミルフェニルアラニン、システイン、およびセリン・バソプレッシン拮抗剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013044654A Pending JP2013151520A (ja) | 2005-07-19 | 2013-03-06 | ベータ−ラクタミルフェニルアラニン、システイン、およびセリン・バソプレッシン拮抗剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8048874B2 (enExample) |
| EP (1) | EP1910346B1 (enExample) |
| JP (2) | JP5328349B2 (enExample) |
| KR (2) | KR101523776B1 (enExample) |
| CN (1) | CN101268068B (enExample) |
| AU (1) | AU2006270039B2 (enExample) |
| BR (1) | BRPI0613664B1 (enExample) |
| CA (1) | CA2615813C (enExample) |
| DK (1) | DK1910346T3 (enExample) |
| ES (1) | ES2726942T3 (enExample) |
| PL (1) | PL1910346T3 (enExample) |
| RU (1) | RU2466991C2 (enExample) |
| SI (1) | SI1910346T1 (enExample) |
| TR (1) | TR201907381T4 (enExample) |
| WO (1) | WO2007011878A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002342045C1 (en) * | 2001-10-12 | 2009-07-30 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl vasopressin Vla antagonists |
| EP1638549A4 (en) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | NEW ANTIBACTERIAL AGENTS |
| CA2601709C (en) | 2005-03-22 | 2017-02-14 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids |
| AU2006270039B2 (en) * | 2005-07-19 | 2013-07-04 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| US20100016274A1 (en) * | 2006-09-14 | 2010-01-21 | Koppel Gary A | Beta-lactam cannabinoid receptor modulators |
| US9453042B2 (en) | 2007-10-25 | 2016-09-27 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| HRP20160222T1 (hr) | 2008-10-24 | 2016-04-08 | Cempra Pharmaceuticals, Inc. | Biozaštite uporabom makrolida koji sadrže triazol |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| WO2012003436A1 (en) * | 2010-07-01 | 2012-01-05 | Azevan Pharmaceuticals, Inc. | Methods for treating post traumatic stress disorder |
| US9815863B2 (en) | 2010-09-10 | 2017-11-14 | Cempra Pharmaceuticals, Inc. | Hydrogen bond forming fluoro ketolides for treating diseases |
| IN2014DN08939A (enExample) | 2012-03-27 | 2015-05-22 | Cempra Pharmaceuticals Inc | |
| CA2905975A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| EP2968384A4 (en) | 2013-03-15 | 2017-02-15 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
| CA2944211C (en) | 2014-03-28 | 2022-10-04 | Azevan Pharmaceuticals, Inc. | Compositions and methods for treating neurodegenerative diseases |
| EP3681871A4 (en) | 2017-09-15 | 2021-05-26 | Azevan Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BRAIN DAMAGE |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| NL7503310A (nl) * | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| US4576753A (en) * | 1975-10-06 | 1986-03-18 | Fujisawa Pharmaceutical Co., Ltd. | Azetidinone compounds and processes for preparation thereof |
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| US4341698A (en) * | 1979-06-21 | 1982-07-27 | Richardson-Merrell Inc. | Enkaphalin derivatives |
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| JPS6033439B2 (ja) * | 1980-03-07 | 1985-08-02 | 財団法人相模中央化学研究所 | ジペプチドの製造方法 |
| JPS56125361A (en) * | 1980-03-07 | 1981-10-01 | Sagami Chem Res Center | Azetidinone compound |
| FR2508035A1 (fr) * | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
| US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
| JPS60112757A (ja) * | 1983-11-18 | 1985-06-19 | Takeda Chem Ind Ltd | 光学活性β−ラクタム類およびその製造法 |
| US4751299A (en) * | 1983-11-18 | 1988-06-14 | Takeda Chemical Industries, Ltd. | Optically active β-lactams and method of their production |
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4734498A (en) * | 1986-07-10 | 1988-03-29 | Eli Lilly And Company | 3β-succinimidoazetidinones as chiral intermediates |
| US4772694A (en) * | 1986-07-24 | 1988-09-20 | Eli Lilly And Company | Chiral 3-(1,2,5-trisubstituted imidazolidinone) azetidinone antibiotic intermediates |
| US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
| US5011472A (en) * | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| GB9204001D0 (en) | 1992-02-25 | 1992-04-08 | Jacobs Suchard Ag | Process for producing reduced fat nuts |
| AU4713293A (en) | 1992-07-13 | 1994-01-31 | Merck Sharp & Dohme Limited | Heterocyclic amide derivatives as tachykinin derivatives |
| EP0655055B1 (en) | 1992-08-13 | 2000-11-29 | Warner-Lambert Company | Tachykinin antagonists |
| FR2696178B1 (fr) | 1992-09-30 | 1994-12-30 | Sanofi Elf | Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
| JP3424174B2 (ja) | 1993-05-06 | 2003-07-07 | メレルダウファーマス−ティカルズ インコーポレイテッド | タキキニン拮抗剤として有用な置換ピロリジン−３−イル−アルキル−ピペリジン類 |
| WO1996035122A1 (en) * | 1995-05-03 | 1996-11-07 | Eli Lilly And Company | Combinatorial process for synthesizing azetidinone analogs |
| US5759865A (en) * | 1995-05-03 | 1998-06-02 | Eli Lilly And Company | Combinatorial process for synthesizing azetidinone analogs |
| JP4212112B2 (ja) * | 1996-02-23 | 2009-01-21 | イーライ・リリー・アンド・カンパニー | 非ペプチジルバソプレッシンＶ１ａアンタゴニスト |
| US6403632B1 (en) * | 2000-03-01 | 2002-06-11 | Bristol Myers Squibb Pharma Co | Lactam metalloprotease inhibitors |
| US6627625B1 (en) * | 1999-08-16 | 2003-09-30 | Revaax Pharmaceuticals, Llc | Treatment of behavioral disorders with β-lactam compounds |
| FR2804114B1 (fr) * | 2000-01-25 | 2002-03-08 | Sanofi Synthelabo | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant |
| GB0019006D0 (en) | 2000-08-04 | 2000-09-20 | Astrazeneca Ab | Novel compounds |
| AU2002342045C1 (en) * | 2001-10-12 | 2009-07-30 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl vasopressin Vla antagonists |
| AU2002359761A1 (en) * | 2001-12-18 | 2003-06-30 | Invenux, Inc. | Antibiotic compounds |
| US7135479B2 (en) * | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| EP2292620A3 (en) * | 2003-07-14 | 2011-06-22 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto |
| US20060281728A1 (en) * | 2003-10-03 | 2006-12-14 | Guillon Christophe D | 3-Substituted beta-lactamyl vasopressin v1a antagonists |
| CA2601709C (en) * | 2005-03-22 | 2017-02-14 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids |
| AU2006270039B2 (en) * | 2005-07-19 | 2013-07-04 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| US20100016274A1 (en) * | 2006-09-14 | 2010-01-21 | Koppel Gary A | Beta-lactam cannabinoid receptor modulators |
-
2006
- 2006-07-18 AU AU2006270039A patent/AU2006270039B2/en not_active Ceased
- 2006-07-18 EP EP06787593.0A patent/EP1910346B1/en active Active
- 2006-07-18 CA CA2615813A patent/CA2615813C/en active Active
- 2006-07-18 BR BRPI0613664-8A patent/BRPI0613664B1/pt not_active IP Right Cessation
- 2006-07-18 RU RU2008106251/04A patent/RU2466991C2/ru active
- 2006-07-18 US US11/996,006 patent/US8048874B2/en active Active
- 2006-07-18 PL PL06787593T patent/PL1910346T3/pl unknown
- 2006-07-18 KR KR1020087003252A patent/KR101523776B1/ko not_active Expired - Fee Related
- 2006-07-18 DK DK06787593.0T patent/DK1910346T3/da active
- 2006-07-18 ES ES06787593T patent/ES2726942T3/es active Active
- 2006-07-18 JP JP2008522861A patent/JP5328349B2/ja not_active Expired - Fee Related
- 2006-07-18 CN CN200680034276.5A patent/CN101268068B/zh not_active Expired - Fee Related
- 2006-07-18 WO PCT/US2006/027703 patent/WO2007011878A2/en not_active Ceased
- 2006-07-18 TR TR2019/07381T patent/TR201907381T4/tr unknown
- 2006-07-18 KR KR1020147015698A patent/KR101521405B1/ko not_active Expired - Fee Related
- 2006-07-18 SI SI200632330T patent/SI1910346T1/sl unknown
-
2011
- 2011-10-31 US US13/285,590 patent/US8426400B2/en not_active Expired - Fee Related
-
2013
- 2013-03-06 JP JP2013044654A patent/JP2013151520A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502788A5 (enExample) | ||
| RU2386620C2 (ru) | Производные пиридазин-3(2н)-она и их применение в качестве ингибиторов фдэ4 | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| PE20080906A1 (es) | Derivados heteroarilo como inhibidores de citocina | |
| ES2572189T3 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis | |
| RU2006116887A (ru) | Производные n-[гетероарил(пиперидин-2-ил)метил]бензамида, способ получения указанных соединений и их применение в терапии | |
| JP2007519631A5 (enExample) | ||
| JP2018501226A5 (enExample) | ||
| RU2010138577A (ru) | ИНГИБИТОРЫ РЕЦЕПТОРА ХЕМОКИНА CxCR3 | |
| PE20030968A1 (es) | Derivados de 5-feniltiazol como inhibidores de cinasas | |
| PE20121313A1 (es) | Derivados de 4-aminociclohexano sustituidos | |
| RU2356888C2 (ru) | Новые азетидиновые соединения | |
| WO2007125315A3 (en) | Pharmaceutical compounds | |
| RU2005138365A (ru) | 3-замещенные-5, 6-диарил-пиразин-2-карбоксамидные и -2-сульфонамидные производные в качестве модуляторов каннабиноидного рецептора 1(св1) | |
| JP2020534274A5 (enExample) | ||
| AR069526A1 (es) | Compuesto heterociclico que contiene nitrogeno y su uso | |
| JP2011512412A5 (enExample) | ||
| RU2009117209A (ru) | 2-пиридинкарбоксамидное производное, обладающее gk-активирующим действием | |
| JP2016503009A5 (enExample) | ||
| JP2011503006A5 (enExample) | ||
| RU2010142936A (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ПИПЕРАЗИНА КАК ИНГИБИТОРЫ СТЕАРОИЛ-КоА ДЕСАТУРАЗЫ | |
| NO20071314L (no) | Peptidiske vasopressinreseptoragonister | |
| AR059094A1 (es) | Derivados de ciclohexil - sulfonamida | |
| PE20120356A1 (es) | Compuestos para el tratamiento de trastornos metabolicos | |
| EA201170795A1 (ru) | Антагонисты ccr2 группы 4-азетидинил-1-гетероарил-циклогексанола |